Evolus EOLS
NASDAQ EOLS
$7.29 -0.08 (-1.09%)
As of: Oct 21, 2026 · 10:07 AM EDT

Evolus (EOLS) Short term Debt (2020)

Updated

Evolus' Short term Debt was $74.38 million in Q4 2020.

Analysis

Evolus (EOLS) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 Evolus 480.62 Mn 288.31 Mn 57.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 74.38 Mn
API Access

Evolus Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=EOLS&period=max&api_key=YOUR_API_KEY